Breast Cancer News and Research

Latest Breast Cancer News and Research

Drinking during adolescence increases risk of benign breast disease in young women

Girls and young women who drink alcohol increase their risk of benign (noncancerous) breast disease, says a study by researchers at Washington University School of Medicine in St. Louis and Harvard University. Benign breast disease increases the risk for developing breast cancer.

12 Apr 2010

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference

Celsion Corporation today announced that Dr. Ronnie T.P. Poon from the University of Hong Kong and lead principal investigator for the Asia Pacific region of the Phase I ThermoDox dose escalation trial will hold a press conference on Thursday, April 15, 2010 at 10:30 AM HKT (Wednesday, April 14, 2010 10:30 PM ET) to discuss the long-term follow-up of patients treated from April 2006 to December 2006.

12 Apr 2010

Three nonprofit organizations launch campaign to increase national awareness of PF

The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.

12 Apr 2010

Global study shows wide variations in treatment of women with early breast cancer

A global study of nearly 10,000 women with early breast cancer has found wide variations in how they were treated, despite international consensus on best practice, according to the May issue of the British Journal of Surgery.

12 Apr 2010

Research opens way for development of new preventions and treatments for breast cancer

Researchers at the Walter and Eliza Hall Institute have discovered that breast stem cells are exquisitely sensitive to the female hormones oestrogen and progesterone, a finding that opens the way for the development of new preventions and treatments for breast cancer.

12 Apr 2010

Three in ten women use letrozole to treat infertility: Study

About three in ten patients using letrozole (Femara), a common medication for treating breast cancer, are likely taking the medication to treat infertility, according to a new study presented today at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime Therapeutics, a thought leader in pharmacy benefit management.

12 Apr 2010

Labour’s cancer leaflet campaign questioned

Last month more than 250,000 personalized leaflets were sent out to women with a warning that a Conservative government would scrap a Labour guarantee that all suspected breast cancer patients would be seen by a specialist within two weeks of GP referral. They also claimed that the Conservative party will take away the right to be treated for cancer within 18 weeks. According to a Sunday Times report some of the recipients of this leaflet were cancer patients or cancer survivors.

12 Apr 2010

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.

9 Apr 2010

Abraxis BioScience to present updated survival findings from ABRAXANE Phase I/II trial at 101st AACR meeting

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.

9 Apr 2010

ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer

ZIOPHARM Oncology, Inc., announced today it has initiated a Phase I/II study at Memorial Sloan-Kettering Cancer Center for the novel, mathematically - determined administration of oral indibulin (Zybulin™ or ZIO-301) in the treatment of metastatic breast cancer.

9 Apr 2010

Merge Healthcare to exhibit expanded suite of women's imaging solutions at NCBC 2010

Merge Healthcare, a health IT solutions leader, today announced it will be showcasing it's expanded suite of innovative solutions and support of comprehensive continuing education programs for the advancement of women's imaging at the National Conference on Breast Cancer (NCBC) 2010. Additionally, Merge plans to introduce and collaborate with attendees on its Women's Healthcare Initiative, which builds partnerships with clinicians to provide broader access to training in the analysis and interpretation of these important studies.

8 Apr 2010

Hospital TV remotes are potential reservoir of bacteria

According to RID (Committee to Reduce Infection Deaths) over thirty billion dollars is spent each year in the US on hospital-acquired infections. (Infections caught while hospitalized). These very preventable infections cost an additional $15,000.00 on average per patient infected and kill more people in this country than AIDS, breast cancer and car accidents combined.

8 Apr 2010

Individuals should act now to prepare for major tax hikes: Kahler Financial Group

The ink is barely dry on the health care bill but individuals should act now to prepare for major tax hikes and possibly higher interest rates, which could increase borrowing costs and require the need to reallocate some investment assets. That's the call from fee-only financial planner Rick Kahler, president of the largest financial planning firm in the seven-state Midwest region, Kahler Financial Group.

8 Apr 2010

OSU-CG12 agent kills cancer cells through energy restriction: Study

Cancer cells grow so fast that they can outstrip their blood supply, leaving them short of oxygen. The cells then produce energy in a way that needs less oxygen but more sugar.

8 Apr 2010

Martina undergoing therapy for breast cancer, urges women to be more vigilant

The tennis legend Martina Navratilova has revealed on Wednesday that she is undergoing therapy for breast cancer. She has always been revered for her health and performance. Just a month short of her 50th birthday, Navratilova won her last grand slam title, the mixed doubles at the 2006 US Open, and in retirement she wrote a 'how-to' book about good living. She was a winner of a record nine Wimbledon singles titles, 59 grand slam titles, including 18 singles trophies and arguably the greatest female athlete of all time.

8 Apr 2010

Prague hosts 12th European Congress of Endocrinology

The 12th European Congress of Endocrinology is taking place in Prague from 24-28 April 2010.

8 Apr 2010

Pair of proteins excreted in urine could lead to earlier diagnosis of kidney cancer: Researchers

Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.

8 Apr 2010

Women living in northeastern U.S. more likely to develop RA: Study

Women living in the northeastern United States are more likely to develop rheumatoid arthritis, suggesting a link between the autoimmune disease and vitamin D deficiency, says a new study led by a Boston University School of Public Health researcher.

8 Apr 2010

Jazzercise, Back in the Swing USA partner to promote breast cancer survivorship programs

Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.

7 Apr 2010

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

7 Apr 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Drinking during adolescence increases risk of benign breast disease in young women

Results of Phase I ThermoDox dose escalation trial to be discussed in a press conference

Three nonprofit organizations launch campaign to increase national awareness of PF

Global study shows wide variations in treatment of women with early breast cancer

Research opens way for development of new preventions and treatments for breast cancer

Three in ten women use letrozole to treat infertility: Study

Labour’s cancer leaflet campaign questioned

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Abraxis BioScience to present updated survival findings from ABRAXANE Phase I/II trial at 101st AACR meeting

ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer

Merge Healthcare to exhibit expanded suite of women's imaging solutions at NCBC 2010

Hospital TV remotes are potential reservoir of bacteria

Individuals should act now to prepare for major tax hikes: Kahler Financial Group

OSU-CG12 agent kills cancer cells through energy restriction: Study

Martina undergoing therapy for breast cancer, urges women to be more vigilant

Prague hosts 12th European Congress of Endocrinology

Pair of proteins excreted in urine could lead to earlier diagnosis of kidney cancer: Researchers

Women living in northeastern U.S. more likely to develop RA: Study

Jazzercise, Back in the Swing USA partner to promote breast cancer survivorship programs

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in